{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T05:23:41Z","timestamp":1676352221435},"reference-count":8,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:p>A 72-year-old man had mild proximal weakness that developed into progressive camptocormia, head drop, numbness, and significant muscle wasting. What is your diagnosis?<\/jats:p>","DOI":"10.1001\/jamaneurol.2022.4441","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T16:00:48Z","timestamp":1670860848000},"page":"209","source":"Crossref","is-referenced-by-count":0,"title":["Progressive Camptocormia With Head Drop and Dysphagia"],"prefix":"10.1001","volume":"80","author":[{"given":"Shadi","family":"El-Wahsh","sequence":"first","affiliation":[{"name":"Neurology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia"},{"name":"South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Triplett","sequence":"additional","affiliation":[{"name":"Neurology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia"},{"name":"University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Con","family":"Yiannikas","sequence":"additional","affiliation":[{"name":"Neurology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia"},{"name":"University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"11","key":"ncg220007r1","first-page":"713","article-title":"Late-onset rod myopathy: a new syndrome?","volume":"41","author":"Engel","year":"1966","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"ncg220007r2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13023-017-0640-2","article-title":"Sporadic late-onset nemaline myopathy: review of 76 cases.","volume":"12","author":"Schnitzler","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"ncg220007r3","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1212\/01.wnl.0000180362.90078.dc","article-title":"Sporadic late onset nemaline myopathy.","volume":"65","author":"Chahin","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"ncg220007r4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00415-018-8741-y","article-title":"Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings.","volume":"265","author":"Monforte","year":"2018","journal-title":"J Neurol"},{"issue":"3","key":"ncg220007r5","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1212\/WNL.0000000000007777","article-title":"Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes.","volume":"93","author":"Naddaf","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"ncg220007r6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Heterogeneity of nemaline myopathy cases with skeletal muscle a-actin gene mutations.","volume":"56","author":"Agrawal","year":"2004","journal-title":"Ann Neurol"},{"issue":"5","key":"ncg220007r7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/WCO.0000000000000477","article-title":"Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance.","volume":"30","author":"Uruha","year":"2017","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"ncg220007r8","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/ijc.v148.11","article-title":"Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.","volume":"148","author":"Kotchetkov","year":"2021","journal-title":"Int J Cancer"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2799184\/jamaneurology_elwahsh_2022_cg_220007_1676273722.04064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T16:02:22Z","timestamp":1676304142000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2799184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.4441","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}